An overview on the therapeutics of neglected infectious diseases—Leishmaniasis and Chagas diseases

K Chanda - Frontiers in Chemistry, 2021 - frontiersin.org
Neglected tropical diseases (NTDs) as termed by WHO include twenty different infectious
diseases that are caused by bacteria, viruses, and parasites. Among these NTDs, Chagas …

Chromanone-A prerogative therapeutic scaffold: an overview

S Kamboj, R Singh - Arabian journal for science and engineering, 2022 - Springer
Chromanone or Chroman-4-one is the most important and interesting heterobicyclic
compound and acts as a building block in medicinal chemistry for isolation, designing and …

Current developments in the synthesis of 4-chromanone-derived compounds

EJ Diana, US Kanchana, TV Mathew - Organic & Biomolecular …, 2021 - pubs.rsc.org
The chroman-4-one framework is a significant structural entity that belongs to the class of
oxygen-containing heterocycles. It acts as a major building block in a large class of …

Modulating leishmanial pteridine metabolism machinery via some new coumarin-1, 2, 3-triazoles: design, synthesis and computational studies

NW Hassan, A Sabt, MAZ El-Attar, M Ora… - European Journal of …, 2023 - Elsevier
In accordance with WHO statistics, leishmaniasis is one of the top neglected tropical
diseases, affecting around 700 000 to one million people per year. To that end, a new series …

The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents

P Linciano, C Pozzi, G Tassone, G Landi… - European Journal of …, 2024 - Elsevier
Abstract Pteridine reductase 1 (PTR1) is a catalytic protein belonging to the folate metabolic
pathway in Trypanosmatidic parasites. PTR1 is a known target for the medicinal chemistry …

Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?

M Marín, M López, L Gallego‐Yerga… - Medicinal Research …, 2024 - Wiley Online Library
Leishmaniasis is a group of neglected tropical diseases caused by at least 20 species of
Leishmania protozoa, which are spread by the bite of infected sandflies. There are three …

QSAR modeling for multi-target drug discovery: Designing simultaneous inhibitors of proteins in diverse pathogenic parasites

VV Kleandrova, L Scotti… - Frontiers in …, 2021 - frontiersin.org
Parasitic diseases remain as unresolved health issues worldwide. While for some parasites
the treatments involve drug combinations with serious side effects, for others, chemical …

Retrospective Review of Chromane Analogues as Anti-protozoal Leads: A Decade's Worth of Evolution

SR Jadhav, B Karan Kumar, RP Joshi… - Current Topics in …, 2023 - ingentaconnect.com
Tropical, vector-borne, and neglected diseases with a limited number of medication
therapies include Leishmaniasis, Malaria, Chagas and Human African Trypanosomiasis …

Virtual screening and the in vitro assessment of the antileishmanial activity of lignans

M dos Santos Maia, JP Raimundo e Silva… - Molecules, 2020 - mdpi.com
Leishmaniasis is endemic in at least 98 countries. Due to the high toxicity and resistance
associated with the drugs, we chose lignans as an alternative, due to their favorable …

Anti-trypanosomatid structure-based drug design–lessons learned from targeting the folate pathway

J Panecka-Hofman, I Poehner… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Trypanosomatidic parasitic infections in humans and animals caused by
Trypanosoma brucei, Trypanosoma cruzi, and Leishmania species pose a significant health …